Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Mongodb,Sign,And,Logo,On,Silicon,Valley,Office,Of,Open
March 6, 2025 11:10 AM 3 min read

MongoDB's Solid Q4 Overshadowed By Weak FY26 Guidance, Expects Non-Atlas Headwinds

by Priya Nigam Benzinga Staff Writer
Follow

Shares of MongoDB Inc (NASDAQ:MDB) tanked in early trading on Thursday, despite the company reporting upbeat fourth-quarter results.

The results came in amid a positive earnings season. Here are some key analyst takeaways.

Wedbush On MongoDB

Analyst Daniel Ives reiterated an Outperform, while cutting the price target from $360 to $300.

MongoDB's total revenues grew 20% year-on-year to $548.4 million, beating Street expectations of $520.6 million, Ives said. Subscription revenue of $531.0 million also came in above consensus of $504.9 million, "as MDB looks to generate stable demand across industries for its next-gen solutions," he added.

NRR (net recurring revenues) stood at 118%, decelerating from 120% in the previous quarter, "due to a smaller contribution from existing customers," the analyst stated. "MongoDB provided relatively weak guidance across the board for FY26 as the company sees a more gradual impact from its AI solutions into FY26," he further wrote.

RBC Capital Markets On MongoDB

Analyst Rishi Jaluria maintained an Outperform rating, while slashing the price target from $400 to $320.

MongoDB closed fiscal 2025 "on a solid note," with non-GAAP earnings of $1.28 per share beating consensus of 66 cents per share, Jaluria said. Although total revenues came in higher than consensus, growth decelerated by 2 points to 20% year-on-year, he added.

The company achieved strong profitability, with operating margins beating consensus by around 900 basis points, the analyst stated. Management's fiscal 2026 guidance was disappointing, being impacted by expectations of "a high single-digit decline in non-Atlas subscription revenue," he further wrote.

Check out other analyst stock ratings.

Rosenblatt Securities On MongoDB

Analyst Blair Abernethy reaffirmed a Buy rating, while reducing the price target from $350 to $305.

MongoDB's subscription revenues grew by 19% year-on-year to $531 million, beating consensus by 6%, Abernethy said. The beat was driven by "greater than expected non-Atlas multi-year contract signings of ~$10m," he added.

While the company expects Atlas consumption growth to remain stable in fiscal 2026, its weaker revenue guidance for the year is impacted "largely by a $50m non-Atlas multi-year license headwind," the analyst stated. "Mongo continues to see a significant longer-term AI opportunity for its highly scalable, flexible document model that handles all data types," he further wrote.

Needham On MongoDB

Analyst Mike Cikos maintained a Buy rating, while slashing the price target from $415 to $270.

MongoDB guided to revenue growth of 16%-17% in the fiscal first quarter to a range of $524.0 million to $529.0 million and 12%-14% growth in fiscal 2026 to $2.240 billion to $2.280 billion, Cikos said. The full-year revenue guidance came well below Street expectations of $2.328 billion, he added.

The company expects non-Atlas subscription revenue to decline by a high-single-digit percentage, the analyst wrote. "All eyes are set squarely on Atlas (71% of Revenue) to drive revenue outperformance," with consumption growth stabilizing and the company poised to benefit from "a stronger cohort of acquired workloads in FY25 versus FY24," he further wrote.

Piper Sandler On MongoDB

Analyst Brent Bracelin maintained an Overweight rating, while cutting the price target from $425 to $280.

MongoDB total revenues grew 19.7% year-on-year to $548 million, "with Atlas upside contributing to a $31M beat to the midpoint guide," Bracelin said. Atlas grew by a healthy 24% year-on-year during the fiscal fourth quarter, although this marked a deceleration from the 26% reported in the previous quarter, he added.

Management indicated that Atlas consumption trends are stabilizing, the analyst stated. Bracelin said, however, that the company's growth outlook came in below 14% for second straight year.

MDB Price Action: Shares of MongoDB had declined by 21.61% to $207.06 at the time of publication on Thursday.

Read More:   Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From ‘Excitement’ To ‘Boredom’

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEarningsBrent BracelinDaniel IvesMike CikosNeedhamPiper SandlerRBC Capital MarketsRishi JaluriaRosenblatt SecuritiesWedbush
MDB Logo
MDBMongoDB Inc
$248.990.40%
Overview
MDB Logo
MDBMongoDB Inc
$248.990.40%
Overview
Comments
Loading...